Concepts (716)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Developing Countries | 82 | 2022 | 2732 | 6.920 |
Why?
|
| Delivery of Health Care | 76 | 2021 | 4872 | 5.800 |
Why?
|
| Investments | 14 | 2020 | 120 | 4.980 |
Why?
|
| Tuberculosis | 47 | 2021 | 1829 | 4.870 |
Why?
|
| Financing, Organized | 18 | 2017 | 198 | 4.690 |
Why?
|
| National Health Programs | 16 | 2019 | 444 | 4.280 |
Why?
|
| Research Support as Topic | 13 | 2020 | 720 | 4.140 |
Why?
|
| Health Policy | 40 | 2021 | 2625 | 3.900 |
Why?
|
| Public Sector | 11 | 2020 | 267 | 2.950 |
Why?
|
| International Cooperation | 27 | 2020 | 1420 | 2.830 |
Why?
|
| Biomedical Research | 22 | 2020 | 3273 | 2.830 |
Why?
|
| Financing, Government | 17 | 2021 | 480 | 2.800 |
Why?
|
| HIV Infections | 60 | 2022 | 15672 | 2.680 |
Why?
|
| Health Services Accessibility | 44 | 2022 | 5028 | 2.650 |
Why?
|
| Malaria | 20 | 2017 | 1088 | 2.620 |
Why?
|
| Financial Support | 12 | 2016 | 121 | 2.590 |
Why?
|
| Health Care Reform | 16 | 2019 | 1247 | 2.430 |
Why?
|
| Research | 13 | 2018 | 2022 | 2.430 |
Why?
|
| Health Services Needs and Demand | 21 | 2019 | 1435 | 2.420 |
Why?
|
| Health Expenditures | 22 | 2023 | 2266 | 2.360 |
Why?
|
| Capital Financing | 6 | 2014 | 55 | 2.290 |
Why?
|
| Health Priorities | 9 | 2021 | 387 | 2.270 |
Why?
|
| Government Programs | 16 | 2021 | 268 | 2.270 |
Why?
|
| Communicable Disease Control | 18 | 2022 | 812 | 2.170 |
Why?
|
| Private Sector | 12 | 2021 | 390 | 2.130 |
Why?
|
| Poverty | 23 | 2022 | 2587 | 1.990 |
Why?
|
| State Medicine | 8 | 2019 | 206 | 1.970 |
Why?
|
| Health Services | 12 | 2021 | 736 | 1.930 |
Why?
|
| Policy Making | 7 | 2021 | 538 | 1.870 |
Why?
|
| Health Care Costs | 17 | 2021 | 3179 | 1.840 |
Why?
|
| Income | 22 | 2022 | 1805 | 1.820 |
Why?
|
| Communicable Diseases | 10 | 2022 | 800 | 1.760 |
Why?
|
| Public Health | 20 | 2022 | 2395 | 1.690 |
Why?
|
| Neoplasms | 28 | 2022 | 20568 | 1.610 |
Why?
|
| Goals | 13 | 2022 | 649 | 1.590 |
Why?
|
| Internationality | 6 | 2021 | 997 | 1.530 |
Why?
|
| Delivery of Health Care, Integrated | 8 | 2016 | 964 | 1.460 |
Why?
|
| World Health Organization | 18 | 2021 | 1287 | 1.440 |
Why?
|
| Humans | 363 | 2023 | 717237 | 1.440 |
Why?
|
| Resource Allocation | 5 | 2017 | 343 | 1.370 |
Why?
|
| Primary Health Care | 14 | 2020 | 4542 | 1.360 |
Why?
|
| Cost of Illness | 13 | 2021 | 1843 | 1.360 |
Why?
|
| Russia | 28 | 2019 | 386 | 1.360 |
Why?
|
| Leadership | 7 | 2021 | 1343 | 1.340 |
Why?
|
| Diabetes Mellitus | 16 | 2022 | 5452 | 1.250 |
Why?
|
| Maternal Mortality | 7 | 2016 | 290 | 1.240 |
Why?
|
| Cost-Benefit Analysis | 14 | 2021 | 5268 | 1.240 |
Why?
|
| Capacity Building | 3 | 2018 | 260 | 1.220 |
Why?
|
| Patient Acceptance of Health Care | 11 | 2020 | 2936 | 1.200 |
Why?
|
| Chronic Disease | 11 | 2021 | 9047 | 1.160 |
Why?
|
| Artificial Intelligence | 5 | 2021 | 1741 | 1.130 |
Why?
|
| Caliciviridae Infections | 2 | 2016 | 26 | 1.100 |
Why?
|
| Unemployment | 7 | 2016 | 200 | 1.090 |
Why?
|
| Developed Countries | 6 | 2020 | 403 | 1.090 |
Why?
|
| Acquired Immunodeficiency Syndrome | 9 | 2013 | 2142 | 1.080 |
Why?
|
| Norovirus | 2 | 2016 | 31 | 1.080 |
Why?
|
| Socioeconomic Factors | 29 | 2022 | 7734 | 1.080 |
Why?
|
| Preventive Health Services | 3 | 2019 | 585 | 1.080 |
Why?
|
| Politics | 10 | 2020 | 757 | 1.070 |
Why?
|
| Financing, Personal | 2 | 2018 | 313 | 1.050 |
Why?
|
| Self-Injurious Behavior | 2 | 2019 | 430 | 1.020 |
Why?
|
| Computer Simulation | 9 | 2022 | 6099 | 0.980 |
Why?
|
| Tuberculosis, Pulmonary | 10 | 2012 | 819 | 0.980 |
Why?
|
| Child Mortality | 4 | 2015 | 190 | 0.950 |
Why?
|
| Antitubercular Agents | 13 | 2012 | 1302 | 0.950 |
Why?
|
| Hospital Administrators | 2 | 2018 | 49 | 0.930 |
Why?
|
| Fund Raising | 2 | 2019 | 41 | 0.920 |
Why?
|
| Infectious Disease Transmission, Vertical | 5 | 2013 | 1318 | 0.910 |
Why?
|
| Health Personnel | 12 | 2022 | 3012 | 0.910 |
Why?
|
| Privatization | 2 | 2020 | 43 | 0.900 |
Why?
|
| Africa South of the Sahara | 11 | 2017 | 689 | 0.890 |
Why?
|
| Reminder Systems | 4 | 2013 | 388 | 0.890 |
Why?
|
| Transients and Migrants | 2 | 2021 | 128 | 0.870 |
Why?
|
| Disease Outbreaks | 8 | 2020 | 1728 | 0.860 |
Why?
|
| Health Education | 6 | 2022 | 1061 | 0.860 |
Why?
|
| Conservation of Natural Resources | 4 | 2017 | 201 | 0.850 |
Why?
|
| Harm Reduction | 4 | 2012 | 115 | 0.830 |
Why?
|
| Financial Management | 2 | 2020 | 154 | 0.830 |
Why?
|
| Mental Disorders | 7 | 2022 | 6431 | 0.820 |
Why?
|
| Models, Economic | 3 | 2020 | 723 | 0.820 |
Why?
|
| Economic Recession | 3 | 2016 | 73 | 0.800 |
Why?
|
| Disabled Persons | 4 | 2019 | 1149 | 0.790 |
Why?
|
| Program Evaluation | 9 | 2019 | 2536 | 0.780 |
Why?
|
| India | 11 | 2022 | 2015 | 0.760 |
Why?
|
| Diffusion of Innovation | 5 | 2015 | 713 | 0.740 |
Why?
|
| Substance Abuse, Intravenous | 5 | 2012 | 484 | 0.740 |
Why?
|
| Health Planning | 5 | 2015 | 241 | 0.740 |
Why?
|
| Anti-HIV Agents | 10 | 2012 | 4056 | 0.740 |
Why?
|
| Insurance, Health | 10 | 2022 | 2498 | 0.730 |
Why?
|
| Maternal Welfare | 2 | 2011 | 118 | 0.720 |
Why?
|
| Prenatal Care | 3 | 2016 | 1032 | 0.720 |
Why?
|
| European Union | 7 | 2017 | 168 | 0.720 |
Why?
|
| Time | 1 | 2020 | 529 | 0.720 |
Why?
|
| Anthelmintics | 1 | 2019 | 57 | 0.710 |
Why?
|
| Healthcare Disparities | 15 | 2021 | 3031 | 0.710 |
Why?
|
| Survival Analysis | 5 | 2020 | 10542 | 0.700 |
Why?
|
| Helminthiasis | 1 | 2019 | 64 | 0.690 |
Why?
|
| Child Health Services | 2 | 2017 | 677 | 0.690 |
Why?
|
| Nervous System Diseases | 2 | 2019 | 1645 | 0.690 |
Why?
|
| Cities | 2 | 2017 | 493 | 0.680 |
Why?
|
| Drug Resistance, Bacterial | 9 | 2022 | 1101 | 0.670 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 7 | 2012 | 873 | 0.660 |
Why?
|
| Epidemics | 4 | 2021 | 485 | 0.660 |
Why?
|
| Prevalence | 28 | 2022 | 14896 | 0.650 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2022 | 3368 | 0.650 |
Why?
|
| Information Dissemination | 2 | 2016 | 1100 | 0.650 |
Why?
|
| Mathematics | 1 | 2019 | 745 | 0.650 |
Why?
|
| Directly Observed Therapy | 8 | 2012 | 143 | 0.640 |
Why?
|
| Cross-Sectional Studies | 42 | 2023 | 23409 | 0.640 |
Why?
|
| Marburgvirus | 1 | 2016 | 17 | 0.640 |
Why?
|
| Hepatitis | 2 | 2019 | 213 | 0.640 |
Why?
|
| Uterine Cervical Neoplasms | 5 | 2020 | 1973 | 0.630 |
Why?
|
| Evidence-Based Practice | 1 | 2021 | 506 | 0.620 |
Why?
|
| Turkey | 5 | 2019 | 232 | 0.620 |
Why?
|
| Quality of Health Care | 6 | 2021 | 4286 | 0.620 |
Why?
|
| Hot Temperature | 1 | 2022 | 1340 | 0.610 |
Why?
|
| Female | 113 | 2022 | 377909 | 0.610 |
Why?
|
| Program Development | 3 | 2012 | 1331 | 0.590 |
Why?
|
| Charities | 2 | 2013 | 32 | 0.590 |
Why?
|
| Prisons | 4 | 2012 | 146 | 0.590 |
Why?
|
| Hospitals | 7 | 2022 | 3372 | 0.590 |
Why?
|
| Hypertension | 8 | 2022 | 8286 | 0.590 |
Why?
|
| Fees and Charges | 1 | 2017 | 195 | 0.580 |
Why?
|
| Work | 1 | 2017 | 193 | 0.580 |
Why?
|
| Social Values | 1 | 2016 | 231 | 0.570 |
Why?
|
| Mortality | 8 | 2019 | 2796 | 0.560 |
Why?
|
| Decision Making, Organizational | 2 | 2013 | 135 | 0.560 |
Why?
|
| Academies and Institutes | 2 | 2014 | 297 | 0.550 |
Why?
|
| Antimalarials | 3 | 2012 | 870 | 0.550 |
Why?
|
| United Nations | 6 | 2018 | 147 | 0.550 |
Why?
|
| Malaysia | 5 | 2020 | 85 | 0.550 |
Why?
|
| Islets of Langerhans | 1 | 2022 | 1407 | 0.540 |
Why?
|
| Hospitalization | 5 | 2022 | 9754 | 0.540 |
Why?
|
| AIDS-Related Opportunistic Infections | 4 | 2010 | 656 | 0.540 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 3 | 2018 | 599 | 0.540 |
Why?
|
| Models, Theoretical | 8 | 2021 | 3566 | 0.540 |
Why?
|
| Population Surveillance | 4 | 2019 | 2633 | 0.540 |
Why?
|
| Computer-Assisted Instruction | 1 | 2018 | 379 | 0.530 |
Why?
|
| Urban Health | 1 | 2017 | 540 | 0.530 |
Why?
|
| Anti-Retroviral Agents | 4 | 2022 | 1602 | 0.530 |
Why?
|
| Anti-Infective Agents | 3 | 2018 | 938 | 0.520 |
Why?
|
| Rural Population | 6 | 2022 | 2168 | 0.520 |
Why?
|
| Child | 32 | 2022 | 74387 | 0.520 |
Why?
|
| Risk Reduction Behavior | 3 | 2011 | 1123 | 0.520 |
Why?
|
| Colonialism | 1 | 2014 | 21 | 0.510 |
Why?
|
| Health Resources | 5 | 2019 | 924 | 0.510 |
Why?
|
| Hospitals, Public | 2 | 2005 | 203 | 0.510 |
Why?
|
| Urban Population | 5 | 2022 | 2025 | 0.510 |
Why?
|
| Ebolavirus | 1 | 2016 | 252 | 0.510 |
Why?
|
| Pregnancy Complications, Infectious | 4 | 2016 | 2034 | 0.500 |
Why?
|
| Diabetes Complications | 2 | 2021 | 1403 | 0.500 |
Why?
|
| Drug Resistance, Microbial | 2 | 2014 | 875 | 0.500 |
Why?
|
| Asia | 7 | 2013 | 640 | 0.490 |
Why?
|
| Appointments and Schedules | 3 | 2013 | 432 | 0.490 |
Why?
|
| Gastroenteritis | 1 | 2016 | 258 | 0.490 |
Why?
|
| Perinatal Care | 2 | 2013 | 231 | 0.490 |
Why?
|
| Adult | 72 | 2022 | 212451 | 0.490 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2014 | 137 | 0.490 |
Why?
|
| Ghana | 4 | 2019 | 276 | 0.480 |
Why?
|
| Healthy People Programs | 2 | 2012 | 57 | 0.480 |
Why?
|
| International Agencies | 2 | 2013 | 242 | 0.480 |
Why?
|
| Male | 87 | 2022 | 351380 | 0.480 |
Why?
|
| Health Surveys | 8 | 2022 | 4023 | 0.480 |
Why?
|
| Cost Savings | 3 | 2020 | 923 | 0.470 |
Why?
|
| Antiretroviral Therapy, Highly Active | 4 | 2021 | 1876 | 0.470 |
Why?
|
| Estonia | 4 | 2016 | 57 | 0.470 |
Why?
|
| Health Plan Implementation | 3 | 2013 | 358 | 0.470 |
Why?
|
| Safety | 2 | 2017 | 1220 | 0.470 |
Why?
|
| Health Services Research | 9 | 2020 | 1837 | 0.470 |
Why?
|
| Disease | 2 | 2016 | 703 | 0.470 |
Why?
|
| Regression Analysis | 12 | 2021 | 6481 | 0.460 |
Why?
|
| Publications | 1 | 2015 | 209 | 0.460 |
Why?
|
| Models, Statistical | 5 | 2021 | 5032 | 0.460 |
Why?
|
| Substance-Related Disorders | 3 | 2022 | 4192 | 0.450 |
Why?
|
| Health Promotion | 5 | 2014 | 2189 | 0.440 |
Why?
|
| Bibliometrics | 1 | 2016 | 336 | 0.440 |
Why?
|
| Infant | 21 | 2021 | 34574 | 0.440 |
Why?
|
| Efficiency, Organizational | 5 | 2019 | 698 | 0.440 |
Why?
|
| Early Detection of Cancer | 5 | 2020 | 2942 | 0.440 |
Why?
|
| Personal Satisfaction | 1 | 2016 | 595 | 0.440 |
Why?
|
| Workload | 2 | 2019 | 859 | 0.440 |
Why?
|
| Surgical Procedures, Operative | 2 | 2020 | 1877 | 0.430 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2016 | 394 | 0.430 |
Why?
|
|